Search Results - "Dushko Dukovski"
-
1
Extranodal Diffuse Large B-Cell Lymphoma of the Small Bowel in Female Patient Causing Intestinal Obstruction: A Case Report
Published in Lietuvos chirurgija (30-12-2022)“…Diffuse large B cell lymphoma is the most common extranodal non-Hodgkin lymphoma of the small intestine accounting for more than 50% of cases. Forty percent of…”
Get full text
Journal Article -
2
-
3
Molecular Aspects in Chronic Lymphocytic Leukemia patients with Autoimmune Cytopenias: single center experience
Published in Hematology, Transfusion and Cell Therapy (01-10-2022)“…Objective: Autoimmune cytopenia's, particularly autoimmune hemolytic anemia (AIHA) and immune thrombocytopenia (ITP), complicate up to 25% of chronic…”
Get full text
Journal Article -
4
-
5
-
6
ABCL-337: High-Dose Chemotherapy Regimens in Therapy of NHL DLBCL: A Single-Center Experience
Published in Clinical lymphoma, myeloma and leukemia (01-09-2021)“…Relapsed-Refractory Diffuse Large B Cell Lymphoma (RR DLBCL), which accounts for approximately one-third of patients with DLBCL, remains a major cause of…”
Get full text
Journal Article -
7
CLL-224 Coronavirus Disease Mortality and Outcome in Macedonian Patients With Chronic Lymphocytic Leukemia: Single-Center Experience
Published in Clinical lymphoma, myeloma and leukemia (01-10-2022)“…Context: Patients with chronic lymphocytic leukemia (CLL) may be more predisposed to coronavirus disease 2019 (COVID-19) due to age, the nature of the disease,…”
Get full text
Journal Article -
8
-
9
CML-575 Spectrum of BCR-ABL Kinase Domain Mutations in North Macedonia in Patients With CML Resistant to Imatinib
Published in Clinical lymphoma, myeloma and leukemia (01-09-2024)“…Most patients treated with first-line tyrosine kinase inhibitor (TKI) imatinib achieve durable response but may lose the response at some point during…”
Get full text
Journal Article -
10
Spectrum of BCR-ABL Kinase Domain Mutations in North Macedonia in Patients With CML Resistant to Imatinib
Published in Clinical lymphoma, myeloma and leukemia (01-09-2024)Get full text
Journal Article -
11
CML-104: Efficacy of Generic Imatinib After Switching from Original in Treatment of Patients with Chronic Myeloid Leukemia in the Republic of North Macedonia - A Single-Center Experience
Published in Clinical lymphoma, myeloma and leukemia (01-09-2020)“…Imatinib, selective tyrosine kinase inhibitor (TKI), revolutionized treatment of chronic myeloid leukemia (CML) and changed the natural history of the disease…”
Get full text
Journal Article -
12
-
13
-
14
CLL-393 Outcomes of COVID-19 Infections in Patients With Hematological Malignancies in Republic of North Macedonia
Published in Clinical lymphoma, myeloma and leukemia (01-10-2022)“…Context: Patients with hematological malignancies are at increased risk of complications and adverse outcomes associated with COVID-19, according to current…”
Get full text
Journal Article -
15
-
16
CLL-132: Mutational Status of IGVH in Correlation with Genetic Abnormalities of Patients with Chronic Lymphocytic Leukemia in Macedonia - A Single-Centre Experience
Published in Clinical lymphoma, myeloma and leukemia (01-09-2020)“…B-cell chronic lymphocytic leukemia (CLL) is a clinically heterogeneous disease. One of the most important molecular predictors, the immunoglobulin VH gene…”
Get full text
Journal Article -
17